ClinicalTrials.gov
public full text
Public Domain
A Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease Through 24 Weeks
The main objective is to assess the efficacy of vonoprazan (10 mg as needed) compared to placebo (as needed) in relief of episodic heartburn at 2 hours that is sustained for 24 hours over 12 weeks of treatment in participants with non-erosive gastroesophageal reflux disease (GERD).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population#968975
- The EndoGastric Solutions TEMPO Trial#840276
- the Impact of Paediatric Use of Proton Pump Inhibitors on the Risk of Community Acquired Infections.#1009005
- Fundic Gland Polyps and Proton Pump Inhibitor (PPI) Drugs#889675
- Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Reflux Disease#826932
Record · ID 857930
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive